Plants that Fight Cancer, Second Edition

★★★★★ 4.8 78 Bewertungen

€15.63
Preis bei Onlinekauf
Kostenloser Versand 30 Tage kostenlose Rückgabe

Verkauft und versendet von internetslayers.com
Wir bemühen uns, Ihnen genaue Produktinformationen anzuzeigen. Hersteller, Lieferanten und andere stellen die hier gezeigten Angaben bereit.
€15.63
Preis bei Onlinekauf
Kostenloser Versand 30 Tage kostenlose Rückgabe

Wie möchten Sie Ihren Artikel erhalten?
Die ersten 30 Tage sind kostenlos! Wählen Sie den Tarif an der Kasse.
Versand
Ankunft 01.10.
Kostenlos
Abholung
In der Nähe prüfen
Lieferung
Nicht verfügbar

Verkauft und versendet von internetslayers.com
30 Tage kostenlose Rückgabe Details

Produktdetails

Artikelnummer 233466217 Erscheinungsdatum 2026/06/27 Listenpreis €15.63 Modellnummer 233466217
Kategorie

Plants that Fight Cancer, Second Edition, is a compilation that reviews cancer treatment and research-based information on the plant kingdom as the source of both known and novel chemical moieties and mixtures, many of them still under identification. This new edition follows the organization of the first book with a considerable expansion of content that more than doubles the volume of information. Divided into four segments, the first part is dedicated to a review of our current knowledge of cancer, the different types and incidence, the molecular pathways of the disease, and the various treatment protocols, with an emphasis on chemotherapy. The second part is a brief journey in pharmacognosy, with detailed information about each of the fourteen different chemical groups of plant secondary metabolites, their use in cancer chemotherapy, and updated information on the biotechnological production of the most representative compounds in clinical practice. The third part of the book comprises six chapters dedicated to either plant chemotherapeutical approaches to specific cancer types (e.g. bladder, prostate) or specific groups of plant secondary metabolites with novel and promising properties for cancer treatment (e.g. naphthoquinones, lectins, phenanthridone alkaloids). The fourth part, containing investigative information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level, is with no doubt the most analytical. This new edition contains chapters on cytotoxic phenanthridone alkaloid constituents of the Amaryllidaceae; naphthoquinone-contained anticancer terrestrial plants; polyphenols and cancer immunology; medicinal plant product-based fabrication nanoparticles (Au and Ag) and their anticancer effects; bladder and prostate cancer; and plant lectins in cancer treatment. FEATURES • Provides efficient information for all kinds of cancer and plant chemotherapeutical approaches to specific cancer types • Discusses specific groups of plant secondary metabolites with novel and promising properties for cancer treatment • Provides scientific information for medicinal uses of various plants • Contains analytical information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level • Focuses on plant genera and species that are either already used in cancer chemotherapy or have been identified with antitumor and antileukemic properties to a bigger or lesser extent Read more

ASIN B07TTV538Y
XRay Not Enabled
Format Print Replica
ISBN13 978-0429616174
Edition 2nd
Language English
File size 30.7 MB
Page Flip Not Enabled
Publisher CRC Press
Word Wise Not Enabled
Print length 544 pages
Accessibility Learn more
Publication date June 26, 2019
Enhanced typesetting Not Enabled

Korrektur der Produktinformationen

Wenn Sie Unvollständigkeiten oder Fehler in den Produktinformationen auf dieser Seite bemerken, nutzen Sie bitte das Korrekturformular unten.

Korrekturanfrage

Kundenbewertungen

4.8 von 5
★★★★★
78 Bewertungen | 32 Rezensionen
So wird die Artikelbewertung berechnet
Alle Bewertungen anzeigen
5 Sterne
87% (68)
4 Sterne
2% (2)
3 Sterne
1% (1)
2 Sterne
0% (0)
1 Stern
10% (8)
Sortieren nach

Für dieses Produkt liegen derzeit keine schriftlichen Bewertungen vor.